Ozempic (Semaglutide for Diabetes) Available in South Africa since 2019 Approved use: Type 2 diabetes management Dosage: Lower doses (up to 1 mg once weekly in SA, higher doses like 2 mg in some markets) Average weight loss: 10-20% of body weight in clinical trials Other benefits: Improves blood sugar control, lowers HbA1c, reduces cardiovascular risks in diabetics In South Africa, Ozempic is not officially approved for weight loss , though some doctors prescribe it off-label to help with obesity
Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dualacting medication that targets both GLP1 and glucosedependent insulinotropic polypeptide (GIP) receptors, which may enhance its effects on appetite regulation and metabolism
After that 30-day window, the potency of the solution may begin to decline even under ideal refrigeration conditions
"I joke that it goes skeletal because it's so incredibly potent." (Topol is not affiliated with Lilly's clinical trials.) We know less about research-lab ret
A pharmacy might offer plain semaglutide at 5 mg/mL but their B12 combination at 3 mg/mL
For a full breakdown of the regulatory landscape, see BPC-157 and the FDA's Category 2 classification